We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Enova International (ENVA - Free Report) : This financial technology and analytics company that offers consumer and small business loans and financing has seen the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
NRG Energy, Inc. NRG: This company which is engaged in production, selling and delivering electricity and related products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 8.4% over the last 60 days.
USANA Health Sciences, Inc. USNA: This developer and manufacturer of nutritional and personal car products used to reduce risks related to chronic degenerative disease has seen the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Synaptics Incorporated SYNA: This developer of human interface solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.
Kemper Corporation KMPR: This provider of property and casualty, and life and health insurance services has seen the Zacks Consensus Estimate for its current year earnings increasing 9.7% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
New Strong Buy Stocks for November 13th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Enova International (ENVA - Free Report) : This financial technology and analytics company that offers consumer and small business loans and financing has seen the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Enova International, Inc. Price and Consensus
Enova International, Inc. price-consensus-chart | Enova International, Inc. Quote
NRG Energy, Inc. NRG: This company which is engaged in production, selling and delivering electricity and related products and services has seen the Zacks Consensus Estimate for its current year earnings increasing 8.4% over the last 60 days.
NRG Energy, Inc. Price and Consensus
NRG Energy, Inc. price-consensus-chart | NRG Energy, Inc. Quote
USANA Health Sciences, Inc. USNA: This developer and manufacturer of nutritional and personal car products used to reduce risks related to chronic degenerative disease has seen the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
USANA Health Sciences, Inc. Price and Consensus
USANA Health Sciences, Inc. price-consensus-chart | USANA Health Sciences, Inc. Quote
Synaptics Incorporated SYNA: This developer of human interface solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.
Synaptics Incorporated Price and Consensus
Synaptics Incorporated price-consensus-chart | Synaptics Incorporated Quote
Kemper Corporation KMPR: This provider of property and casualty, and life and health insurance services has seen the Zacks Consensus Estimate for its current year earnings increasing 9.7% over the last 60 days.
Kemper Corporation Price and Consensus
Kemper Corporation price-consensus-chart | Kemper Corporation Quote
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>